Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-09-02 4:06 pm Purchase | 2025-08-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 2,374,085 11.280% | 399,500![]() (+20.23%) | Filing History |
2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Adage Capital Management, L.P. | 6,800,000 9.880% | 1,050,000![]() (+18.26%) | Filing History |
2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | TScan Therapeutics, Inc. TCRX | Adage Capital Management, L.P. | 1,350,000 2.520% | 1,350,000![]() (New Position) | Filing History |
2025-08-12 09:07 am Purchase | 2025-06-30 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Adage Capital Management, L.P. | 8,800,000 9.870% | 3,102,395![]() (+54.45%) | Filing History |
2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | Tango Therapeutics, Inc. TNGX | Adage Capital Management, L.P. | 5,905,349 5.450% | 5,905,349![]() (New Position) | Filing History |
2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | DBV Technologies S.A. DBVT | Adage Capital Management, L.P. | 14,614,449 9.990% | 14,614,449![]() (New Position) | Filing History |
2025-08-12 09:06 am Purchase | 2025-06-30 | 13G | Adagio Medical Holdings, Inc. ADGM | Adage Capital Management, L.P. | 821,261 5.340% | 821,261![]() (New Position) | Filing History |
2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Janux Therapeutics, Inc. JANX | Adage Capital Management, L.P. | 2,525,000 4.270% | -536,750![]() (-17.53%) | Filing History |
2025-08-12 09:05 am Sale | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Adage Capital Management, L.P. | 3,575,964 7.100% | -816,732![]() (-18.59%) | Filing History |
2025-08-12 09:05 am Purchase | 2025-06-30 | 13G | Immunic, Inc. IMUX | Adage Capital Management, L.P. | 10,479,337 9.990% | 9,080,737![]() (+649.27%) | Filing History |
2025-08-12 09:04 am Purchase | 2025-06-30 | 13G | Wave Life Sciences Ltd. WVE | Adage Capital Management, L.P. | 15,016,500 9.650% | 2,500,000![]() (+19.97%) | Filing History |
2025-08-12 09:04 am Sale | 2025-06-30 | 13G | Seadrill Limited SDRL | Adage Capital Management, L.P. | 3,138,286 5.040% | -1,062,249![]() (-25.29%) | Filing History |
2025-08-12 09:04 am Purchase | 2025-06-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 9,002,580 9.990% | 5,368,105![]() (+147.70%) | Filing History |
2025-08-12 09:03 am Sale | 2025-06-30 | 13G | ProQR Therapeutics N.V. PRQR | Adage Capital Management, L.P. | 6,601,938 6.270% | -1,500,160![]() (-18.52%) | Filing History |
2025-08-12 09:03 am Unchanged | 2025-06-30 | 13G | Ensysce Biosciences, Inc. ENSC | Adage Capital Management, L.P. | 74,711 3.150% | 0 (Unchanged) | Filing History |
2025-08-12 09:02 am Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Adage Capital Management, L.P. | 1,100,000 4.970% | 110,000![]() (+11.11%) | Filing History |
2025-08-12 09:02 am Unchanged | 2025-06-30 | 13G | Inozyme Pharma, Inc. INZY | Adage Capital Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
2025-08-12 09:02 am Unchanged | 2025-06-30 | 13G | Zeo Energy Corp. ZEO | Adage Capital Management, L.P. | 760,000 3.220% | 0 (Unchanged) | Filing History |
2025-08-12 09:02 am Purchase | 2025-06-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Adage Capital Management, L.P. | 1,974,585 9.690% | 231,827![]() (+13.30%) | Filing History |
2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | Centessa Pharmaceuticals plc CNTA | Adage Capital Management, L.P. | 8,403,000 6.290% | 1,449,000![]() (+20.84%) | Filing History |